Lobbying client
MAGSARI BIOSCIENCES, LLC
Development and distribution of a citrus-based antiviral solution.
Filings
3
Filed by
1
Reported in-house
—
Reported by firms
$25,000
Filings
3 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2020
|
WILLIAM WATSON GROUP LLC | $10,000 reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
WILLIAM WATSON GROUP LLC | $15,000 reported |
|
Registration 3rd Quarter 2020
|
WILLIAM WATSON GROUP LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| WILLIAM WATSON GROUP LLC | 2 | $25,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 3 |
| Disaster Planning/Emergencies | DIS | 2 |
| Environment/Superfund | ENV | 2 |
| Chemicals/Chemical Industry | CHM | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.